查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594436

無針注射系統市場：按技術、產品、可用性、最終用戶、應用分類 - 2025-2030 年全球預測

Needle Free Injection System Market by Technology, Product, Usability, End-user, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年無針注射系統市值為225.8億美元，預計2024年將達253億美元，複合年成長率為12.11%，預計到2030年將達到502.8億美元。

無針注射系統是一種創新的藥物輸送技術，無需使用針頭即可給藥，最大限度地減少疼痛並提高患者的依從性。此類系統的範圍擴展到慢性病管理和免疫計劃，為傳統注射提供無痛替代方案。對此類系統的需求源於對患者友好且安全的藥物輸送方法的需求，以減少針刺傷害和針頭恐懼症症等風險。此類系統可應用於各個領域，包括醫院、診所和居家醫療，主要最終用途包括糖尿病管理、疫苗接種和生技藥品管理。市場成長受到慢性病增加、技術進步以及對微創手術日益偏好等因素的顯著影響。然而，同時，這個市場正在應對各種挑戰，例如設備成本高、監管障礙以及提供各種藥物的技術限制。

主要市場統計
基準年[2023] 225.8億美元
預測年份 [2024] 253億美元
預測年份 [2030] 502.8億美元
複合年成長率（%） 12.11%

機會比比皆是，尤其是在越來越重視醫療保健和最新醫療技術的新興市場。隨著技術創新不斷提高送貨量並拓寬可輸送藥物的頻譜，預計將進一步成長。市場還可以透過醫療保健提供者和製造商之間的夥伴關係來提高採用率。儘管前景光明，但公司必須投資適合不同製藥需求的經濟實惠且多功能的系統來應對挑戰。加速微注射器和液體噴射器的進步，並將物聯網等智慧技術整合到資料主導的健康管理中，可以為創新鋪平道路。無針注射器市場的性質正在逐漸發展，其特點是高研究活動和競爭性開發努力，特別是在北美和歐洲等地區。為了取得成功，公司必須跟上監管變化，參與研發，並尋求合作以擴大產品系列和地理覆蓋範圍。

市場動態：快速發展的無針注射系統市場的關鍵市場洞察

無針注射系統市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病盛行率和傳染病發生率增加
    • 生物相似藥和疫苗的藥物傳輸需求增加
    • 自動注射器的需求不斷增加
  • 市場限制因素
    • 巨大的開發成本和嚴格的設備法規
  • 市場機會
    • 糖尿病盛行率和報告病例增加
    • 融合先進技術
  • 市場挑戰
    • 嚴格的設備規定

波特五力：駕馭無針注射系統市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解無針注射系統市場的外部影響

外部宏觀環境因素在塑造無針注射系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解無針注射系統市場的競爭狀況

對無針注射系統市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣無針注射系統市場供應商的績效評估

FPNV定位矩陣是評估無針注射系統市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了無針注射系統市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對無針注射系統市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病盛行率和感染疾病率增加
      • 對生物相似藥和疫苗藥物傳遞的需求增加
      • 自動注射器需求增加
    • 抑制因素
      • 巨大的開發成本和嚴格的設備法規
    • 機會
      • 糖尿病盛行率和報告病例數不斷增加
      • 融合先進技術
    • 任務
      • 與設備相關的嚴格規定
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章無針注射系統市場：依技術分類

  • 噴射式無針注射器
  • 雷射驅動無針注射器
  • 彈簧式無針注射器
  • 振動無針注射器

第7章無針注射系統市場：依產品

  • 可填充無針注射器
  • 預填充無針注射器

第8章無針注射系統市場：按可用性

  • 一次性無針注射器
  • 可重複使用的無針注射器

第 9 章 無針注射系統市場：依最終使用者分類

  • 家庭護理設置
  • 醫院和診所
  • 製藥和生物技術公司
  • 研究室

第10章無針注射系統市場：依應用

  • 胰島素給藥
  • 腫瘤學
  • 疼痛管理
  • 疫苗

第11章 美洲無針注射系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區無針注射系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東和非洲無針注射系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Aijex Pharma International Inc.
  • Amsino International, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Covestro AG
  • Crossject SA
  • D'Antonio Consultants International, Inc.
  • Endo International PLC
  • European Pharma Group BV
  • Ferring BV
  • Inovio Pharmaceuticals, Inc.
  • Medical International Technology, Inc.
  • PenJet Corporation
  • PharmaJet, Inc.
  • Portal Instruments, Inc.
  • Zogenix, Inc.
Product Code: MRR-FB6C9E792CB8

The Needle Free Injection System Market was valued at USD 22.58 billion in 2023, expected to reach USD 25.30 billion in 2024, and is projected to grow at a CAGR of 12.11%, to USD 50.28 billion by 2030.

The needle-free injection system is a transformative innovation in drug delivery that enables medication administration without needles, thereby minimizing pain and enhancing patient compliance. The scope of these systems encompasses not just chronic disease management but also vaccination programs, offering a pain-free alternative to traditional injections. The necessity for such systems stems from the demand for patient-friendly and safe drug delivery methods, reducing risks such as needle-stick injuries and needle phobia. These systems find application across various sectors including hospitals, clinics, and home care settings, with major end-uses in diabetes management, vaccination, and biologics delivery. Market growth is significantly influenced by factors such as an increase in chronic diseases, technological advancements, and the rising preference for minimally invasive procedures. Concurrently, however, the market grapples with challenges like high device costs, regulatory hurdles, and technical limitations in delivering a broad spectrum of drugs.

KEY MARKET STATISTICS
Base Year [2023] USD 22.58 billion
Estimated Year [2024] USD 25.30 billion
Forecast Year [2030] USD 50.28 billion
CAGR (%) 12.11%

Opportunities abound, particularly in emerging markets where healthcare accessibility and modern medical technologies are increasingly prioritized. Continued innovation in improving delivery volumes and broadening the spectrum of deliverable medications can unlock further growth. The market is also poised to benefit from partnerships between healthcare providers and manufacturers to boost adoption rates. Despite promising prospects, businesses must mitigate challenges by investing in affordable and versatile systems tailored to diverse pharmaceutical needs. Fostering advancements in micro-injectors and liquid jets, and integrating smart technologies such as IoT for data-driven health management can pave the way for innovation. The nature of the needle-free injection market is progressively evolving, characterized by a high degree of research activity and competitive development efforts, particularly in regions like North America and Europe. To thrive, companies should stay abreast of regulatory changes, engage in R&D, and explore collaborations that widen their product portfolios and geographical reach.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Needle Free Injection System Market

The Needle Free Injection System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic disease and incidence of communicable disease
    • Increasing demand in drug delivery for biosimilars and vaccination
    • Rising demand for self-injection devices
  • Market Restraints
    • Huge development costs, and stringent device regulations
  • Market Opportunities
    • Growing prevalence and reported cases of diabetes
    • Integration of advance technology
  • Market Challenges
    • Stringent regulations associated with devices

Porter's Five Forces: A Strategic Tool for Navigating the Needle Free Injection System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Needle Free Injection System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Needle Free Injection System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Needle Free Injection System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Needle Free Injection System Market

A detailed market share analysis in the Needle Free Injection System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Needle Free Injection System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Needle Free Injection System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Needle Free Injection System Market

A strategic analysis of the Needle Free Injection System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Needle Free Injection System Market, highlighting leading vendors and their innovative profiles. These include Aijex Pharma International Inc., Amsino International, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Covestro AG, Crossject SA, D'Antonio Consultants International, Inc., Endo International PLC, European Pharma Group B.V., Ferring B.V., Inovio Pharmaceuticals, Inc., Medical International Technology, Inc., PenJet Corporation, PharmaJet, Inc., Portal Instruments, Inc., and Zogenix, Inc..

Market Segmentation & Coverage

This research report categorizes the Needle Free Injection System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Jet-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Spring-Based Needle-Free Injectors, and Vibration-Based Needle-Free Injectors.
  • Based on Product, market is studied across Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors.
  • Based on Usability, market is studied across Disposable Needle-Free Injectors and Reusable Needle-Free Injectors.
  • Based on End-user, market is studied across Homecare Settings, Hospitals and Clinics, Pharmaceutical and Biotechnology companies, and Research Laboratories.
  • Based on Application, market is studied across Insulin Delivery, Oncology, Pain Management, and Vaccine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic disease and incidence of communicable disease
      • 5.1.1.2. Increasing demand in drug delivery for biosimilars and vaccination
      • 5.1.1.3. Rising demand for self-injection devices
    • 5.1.2. Restraints
      • 5.1.2.1. Huge development costs, and stringent device regulations
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing prevalence and reported cases of diabetes
      • 5.1.3.2. Integration of advance technology
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations associated with devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Needle Free Injection System Market, by Technology

  • 6.1. Introduction
  • 6.2. Jet-Based Needle-Free Injectors
  • 6.3. Laser-Powered Needle-Free Injectors
  • 6.4. Spring-Based Needle-Free Injectors
  • 6.5. Vibration-Based Needle-Free Injectors

7. Needle Free Injection System Market, by Product

  • 7.1. Introduction
  • 7.2. Fillable Needle-Free Injectors
  • 7.3. Prefilled Needle-Free Injectors

8. Needle Free Injection System Market, by Usability

  • 8.1. Introduction
  • 8.2. Disposable Needle-Free Injectors
  • 8.3. Reusable Needle-Free Injectors

9. Needle Free Injection System Market, by End-user

  • 9.1. Introduction
  • 9.2. Homecare Settings
  • 9.3. Hospitals and Clinics
  • 9.4. Pharmaceutical and Biotechnology companies
  • 9.5. Research Laboratories

10. Needle Free Injection System Market, by Application

  • 10.1. Introduction
  • 10.2. Insulin Delivery
  • 10.3. Oncology
  • 10.4. Pain Management
  • 10.5. Vaccine

11. Americas Needle Free Injection System Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Needle Free Injection System Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Needle Free Injection System Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aijex Pharma International Inc.
  • 2. Amsino International, Inc.
  • 3. B. Braun Melsungen AG
  • 4. Baxter International Inc.
  • 5. Becton, Dickinson and Company
  • 6. Covestro AG
  • 7. Crossject SA
  • 8. D'Antonio Consultants International, Inc.
  • 9. Endo International PLC
  • 10. European Pharma Group B.V.
  • 11. Ferring B.V.
  • 12. Inovio Pharmaceuticals, Inc.
  • 13. Medical International Technology, Inc.
  • 14. PenJet Corporation
  • 15. PharmaJet, Inc.
  • 16. Portal Instruments, Inc.
  • 17. Zogenix, Inc.

LIST OF FIGURES

  • FIGURE 1. NEEDLE FREE INJECTION SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. NEEDLE FREE INJECTION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. NEEDLE FREE INJECTION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEEDLE FREE INJECTION SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEEDLE FREE INJECTION SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY JET-BASED NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY LASER-POWERED NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SPRING-BASED NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY VIBRATION-BASED NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY FILLABLE NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PREFILLED NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY DISPOSABLE NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY REUSABLE NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. NEEDLE FREE INJECTION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. NEEDLE FREE INJECTION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023